Skip to main content
Clinical Trials/IRCT20120918010876N4
IRCT20120918010876N4
Completed
Phase 2

Assessment of effect of antenatal betamethasone administration on neonatal respiratory morbidity in early term (37 to 38 weeks and 6 days) elective cesarean section

Shahid Beheshti University of Medical Sciences0 sites220 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Respiratory distress syndrome of newborn.
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
220
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • referring women for early or 37 to 38 weeks and 6 days elective cesarean section
  • singleton pregnancy

Exclusion Criteria

  • multiple pregnancies
  • fetus with major congenital anomalies
  • fetus with other medical or midwifery conditions that give birth earlier
  • receive dexamethasone or betamethasone during pregnancy
  • maternal severe hypertension
  • maternal history of peptic ulcer
  • evidences of intrauterine infection

Outcomes

Primary Outcomes

Not specified

Similar Trials